D. Gillespie

发表

A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery.

Randy Jensen, Zheng-Rong Lu, Zheng-Rong Lu, 2008, Biomaterials.

Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice.

Zheng-Rong Lu, Xu-li Wang, R. Xu, 2009, Molecular pharmaceutics.

ELTD1, a potential new biomarker for gliomas.

Cory B. Giles, J. Wren, H. Colman, 2013, Neurosurgery.

Efficient ADCC- killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.

Deric M. Park, M. Gilbert, Wei Zhang, 2019, JCI insight.

Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas

D. Gillespie, R. Jensen, B. Ragel, 2006, Journal of Neuro-Oncology.

Correlation of Glioma Proliferation and Hypoxia by Luciferase, Magnetic Resonance, and Positron Emission Tomography Imaging.

K. Horn, M. Karsy, D. Gillespie, 2018, Methods in molecular biology.

RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.

M. Tan, Zheng-Rong Lu, Xu-li Wang, 2015, Journal of neurosurgery.

Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.

E. Hsu, O. Abdullah, R. Floyd, 2013, Neuro-oncology.

In vivo Interference Attenuates Human Glioma Cell Growth by RNA α Silencing of Hypoxia Inducible Factor-1

D. Gillespie, B. Ragel, K. Whang, 2007 .

Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis

W. Couldwell, D. Gillespie, R. Jensen, 2007, Neurosurgical Review.

A comparison of the cell lines used in meningioma research.

W. Couldwell, D. Gillespie, R. Jensen, 2008, Surgical neurology.

A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation.

W. Couldwell, D. Gillespie, R. Jensen, 2008, Journal of neurosurgery.

CALCIUM CHANNEL ANTAGONISTS AUGMENT HYDROXYUREA‐ AND RU486‐INDUCED INHIBITION OF MENINGIOMA GROWTH IN VIVO AND IN VITRO

D. Gillespie, R. Jensen, Nika V Polevaya, 2006, Neurosurgery.

Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.

D. Gillespie, R. Jensen, B. Ragel, 2006, Journal of neuro-oncology.

Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells.

G. Botta, D. Gillespie, G. Portella, 2013, Endocrine-related cancer.

R-flurbiprofen, a novel nonsteroidal anti-inflammatory drug, decreases cell proliferation and induces apoptosis in pituitary adenoma cells in vitro

W. Couldwell, D. Gillespie, J. Liu, 2012, Journal of Neuro-Oncology.

Celecoxib inhibits meningioma tumor growth in a mouse xenograft model

W. Couldwell, D. Gillespie, S. Prescott, 2007, Cancer.

Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.

W. Couldwell, D. Gillespie, R. Jensen, 2005, Journal of neurosurgery.

Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies.

M. Karsy, D. Gillespie, R. Jensen, 2016, World neurosurgery.

Intermittent Induction of HIF-1α Produces Lasting Effects on Malignant Progression Independent of Its Continued Expression

H. Colman, L. Huang, D. Gillespie, 2015, PloS one.

IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment

S. Tripp, L. Huang, D. Gillespie, 2018, Oncotarget.

Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.

Michael L Mumert, Matthias C Schabel, M. Schabel, 2014, Neuro-oncology.

Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential.

L. Huang, D. Gillespie, R. Jensen, 2020, Journal of neuro-oncology.

Direct DNA methylation profiling using methyl binding domain proteins.

A. Badran, D. Myszka, D. Gillespie, 2010, Analytical chemistry.

Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma.

D. Gillespie, R. Jensen, M. Womeldorff, 2014, Neurosurgical focus.

Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.

P. House, L. Layfield, D. Gillespie, 2004, Journal of neurosurgery.

– Lindau disease : the role of genetic mutation , von Hippel – Lindau protein , and hypoxia inducible factor-1 expression

Von Hippel, L. Layfield, D. Gillespie, 2004 .

PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma

G. Botta, G. Perruolo, D. Gillespie, 2015, Molecular oncology.

Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional cerebrospinal fluid (CSF) cultures among children undergoing treatment for CSF shunt infection.

B. van Yserloo, A. Blaschke, D. Gillespie, 2014, Diagnostic microbiology and infectious disease.

Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo.

S. Tripp, D. Gillespie, R. Jensen, 2009, Methods in molecular biology.

Silencing of Hypoxia Inducible Factor-1α by RNA Interference Attenuates Human Glioma Cell Growth In vivo

D. Gillespie, R. Jensen, B. Ragel, 2007, Clinical Cancer Research.

Hypoxia‐regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme

D. Gillespie, R. Jensen, A. Kinney, 2008, Cancer.

OKN‐007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model

O. Abdullah, K. Fung, D. Saunders, 2015, Journal of magnetic resonance imaging : JMRI.

Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.

D. Castro, J. Nemunaitis, L. Selk, 2001, Archives of Otolaryngology - Head and Neck Surgery.

Silencing of hypoxia inducible factor-1 α by RNA interference attenuates human glioma cell growth in vivo (Clinical Cancer Research (2007) 13 (2441-2448))

D. Gillespie, R. Jensen, B. Ragel, 2008 .

A comparison of the cell lines used in meningioma research.

W. Couldwell, D. Gillespie, R. Jensen, 2008, Surgical neurology.

PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma

G. Botta, D. Gillespie, G. Portella, 2015, Molecular oncology.